| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V5198 | (R)-Oxiracetam (ISF-2522) | 68252-28-8 | R)-Oxiracetam is the R-isomer of oxiracetam (also known as ISF 2522), which is a widely used nootropic drug and improves memory and learning in patients with cognitive impairments. |
|
V2169 | (Rac)-LM11A-31 dihydrochloride | 1214672-15-7 | Rac)-LM11A-31 dihydrochloride is an isomer of LM11A-31 dihydrochloride. |
|
V5041 | NSC139021 (ERGi-USU) | 1147-56-4 | NSC139021 (also known as ERGi-USU) is a novel, potent and highly selective inhibitor for the growth of ERG-positive cancer cells with IC50s ranging from 30 to 400 nM. |
|
V4740 | BD-AcAc 2 | 1208313-97-6 | BD-AcAc 2, usually added in diet and given orally, can elevate mean blood ketone bodies of 3.5 mm and lowered plasma glucose, insulin, and leptin in animals. |
|
V2192 | CCRP2 (TLXagonist 1) | 958323-31-4 | CCRP2(also known as TLX agonist 1 and SUN-23314) ,is a novel orphan nuclear receptor tailless (TLX, NR2E1) modulator (EC50=1μM; Kd= 650 nM). |
|
V4835 | EphB1-IN-10 | 2097512-73-5 | EphB1-IN-10 is a novel, potent, selective and irreversible/covalent inhibitor of receptor tyrosine kinase EphB1. |
|
V4947 | Fluticasone furoate | 397864-44-7 | Fluticasone furoate is a topical, intranasal, enhanced affinity synthetic trifluorocorticosteroid with Kd of 0.3 nM. |
|
V4921 | GLL-398 | 2077980-83-5 | GLL398 (GLL-398) is a novel, potent, orally bioavailable, and selective estrogen receptor downregulator. |
|
V4545 | GNE-140 racemate | 1809794-70-4 | GNE-140 racemate is a novel and potent lactate dehydrogenase (LDHA) inhibitor which is a racemic mixture of (R)-GNE-140 and (S)-GNE-140. |
|
V4863 | GSK-3008348 | 1629249-33-7 | GSK-3008348 (GSK3008348), an investigational drug, is a novel and potent integrin alpha(v)beta6 antagonist thatis being developed by GlaxoSmithKline Research and Development Limited (the Sponsor, a pharmaceutical company based in the UK) for the treatment of Idiopathic Pulmonary Fibrosis (IPF). |
|
V4871 | LY334370 HCl | 199673-74-0 | LY-334370 HCl, the hydrochloride of LY-334370, is a novel, potent and selective 5-HT1F receptor agonist with Ki values of 1.6 nM. |
|
V5016 | NSC-41589 | 6310-41-4 | NSC-41589 is N-[2-(methylsulfanyl) phenyl]acetamide. |
|
V4780 | PCI-27483 | 871266-63-6 | PCI-27483 is a novel, potent and reversible small-molecule inhibitor of activated factor VII (factor VIIa) with potential anticancer and antithrombotic activities. |
|
V2174 | RETV804M inhibitor | 2414373-42-3 | RET-IN-21 is a receptor tyrosine kinase (RET) inhibitor (antagonist) with IC50 of 4.4 μM and anti-tumor activity. |
|
V4811 | Ro 10-5824 | 189744-46-5 | Ro 10-5824 is a novel, potent and selectivepartial agonist of dopamine D4 receptorwithKiof 5.2 nM. |
|
V4611 | SB-224289 | 180083-23-2 | SB-224289 is a novel, potent and selective5-HT1B receptorantagonist with anxiolytic effect with pKi of 8.2. |
|
V2164 | SC-26196 | 218136-59-5 | SC-26196 is a novel, potent and orally bioactive D6D (Delta6 desaturase) inhibitor with IC50 of 0.2 µM in a rat liver microsomal assay. |
|
V4670 | SCH00013 | 217963-18-3 | SCH00013 is a novel and potent Ca2+ sensitizer that elicits a moderate positive inotropic effect without significant alteration of Ca2+ transients. |
|
V4800 | SJA710-6 | 1397255-09-2 | SJA710-6 (a Hepatic Differentiation Inducer) is a novel, potent and cell-permeable small moleculeimidazopyridinamine compound that is able to induce the differentiation of rat MSCs (rMSCs) toward hepatocyte-like cells(~47% at 5 µM). |
|
V5053 | SKI-II HCl | 1177741-83-1 | SKI-II HCl is a substrate competitive, reversible, and highly specific inhibitor of sphingosine kinase. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
